VX Pharma - About the company
VX Pharma is a funded company based in Pretoria (South Africa), founded in 2009 by Mark Fyvie and Paul Abrahams. It operates as a Provider of phase I to IV clinical trials services. The company has 47 active competitors, including 4 funded and 3 that have exited. Its top competitors include companies like United BioSource Corporation, Hikinger Pharmaceutical Technology and River Vision Development.
Company Details
- Website
- vxpharma.com
- Social
- Email ID
- *****@vxpharma.com
- Phone Number
- +27 **********
Key Metrics
Founded Year
2009
Location
Pretoria, South Africa
Stage
Funding Raised
Investors
Ranked
8th among 47 active competitors
Employee Count
7 as on Jul 01, 2024
Similar Companies
Sign up to download VX Pharma's company profile
VX Pharma's funding and investors
VX Pharma is a funded company. VX Pharma has 1 institutional investor.
View details of VX Pharma's funding rounds and investors
VX Pharma's founders and board of directors
Founder? Claim ProfileHere are the details of VX Pharma's key team members:
- Mark Fyvie: Co-Founder & CEO of VX Pharma. Contact Info: 1 email address
- Paul Abrahams: Co-Founder of VX Pharma.
View details of VX Pharma's Founder profiles and Board Members
VX Pharma's employee count trend
VX Pharma has 7 employees as of Jul 24. Here is VX Pharma's employee count trend over the years:
Uncover VX Pharma's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
VX Pharma's Competitors and alternates
Top competitors of VX Pharma include United BioSource Corporation, Hikinger Pharmaceutical Technology and River Vision Development. Here is the list of Top 10 competitors of VX Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | United BioSource Corporation 2003, Blue Bell (United States), Acquired | Uniting evidence and access to improve patient outcomes for biopharma | $278M | 60/100 | |
2nd |  Hikinger Pharmaceutical Technology 2006, Beijing (China), Series B | Provider of phase I-IV drug research and development services | - | 29/100 | |
3rd |  River Vision Development 2011, Series A | Provider of late stage clinical development services | $17M | 28/100 | |
4th |  US Biotest 2000, San Luis Obispo (United States), Funding Raised | Provider of late-stage clinical trials studies for multiple therapeutic diseases | - | 26/100 | |
5th | Concentrics Research 1999, Indianapolis (United States), Acquired | Late-stage (Phase II-IV trials) CRO | - | - | 26/100 |
6th | CRO helping life sciences companies by setting-up and managing clinical trials | $200K | 26/100 | ||
7th | Indian CRO offering comprehensive clinical research and site-management services for for phase II - IV clinical studies | - | - | 26/100 | |
8th | VX Pharma 2009, Pretoria (South Africa), Funding Raised | Provider of phase I to IV clinical trials services | - | 24/100 | |
9th | Provider of online airport parking space booking and management services | - | - | 24/100 | |
10th | O4 Research 2009, Belfast (United Kingdom), Unfunded | Manufacturer of conductive metal-clad fibers for diverse applications | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on VX Pharma's competitors? Click here to see the top ones
VX Pharma's Investments and acquisitions
VX Pharma has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about VX Pharma
Explore our recently published companies
- Kavenex Energy - Calgary based, 2025 founded, Unfunded company
- Invela Network - Salt Lake City based, 2024 founded, Unfunded company
- Inharu Beverages - Bengaluru based, 2025 founded, Unfunded company
- PhoneWale - India based, 2017 founded, Unfunded company
- Jurassic World Evolution - London based, Unfunded company
- Curelink - 2024 founded, Unfunded company
